Both of the women can communicate without an implant. The first, Pat Bennett, who has ALS, also known as Lou Gehrig's disease, uses a computer to type. The second, Ann Johnson, who lost her voice as the result of a brain-stem stroke that left her paralyzed, uses an eye-tracking device to select letters on a computer screen. That ability to communicate is what gave them the power to consent to participate in these trials. But how does consent work when communication is more difficult?

Former employees said that leadership decision-making was diffuse. Some major decisions came from Arons, while others came from Roberts -- sometimes through Joe Marsh, an executive at Comcast Spectacor and close collaborator of Roberts. Marsh did not officially join G4 until summer 2022, but former employees said he was involved in the operation, especially on the esports side of the network, as far back as summer 2021. Roberts, meanwhile, continued to sporadically meet with talent after Arons took over, according to former G4 staff.

Artificial intelligence (AI) has transformed the life sciences industry in ways that we could never have imagined. Recognising the potential benefits, industry leaders across the world have increased investment in AI, with the global AI healthcare market expected to grow from US$4.9 billion in 2020 to US$45.2 billion by 2026. The COVID-19 pandemic has further intensified focus on the application of AI across the entire value chain. While companies from all industries adapted to the "new normal" of daily remote collaboration and AI technologies, life science companies also leaned more heavily into the use of AI in their mainstay work of drug and medicine development and marketing. The development and bringing to market of COVID-19 vaccines in less than a year is testament to the power of AI, as well as the remarkable collaboration of industry stakeholders. Post-pandemic, there is no doubt that the industry is primed to harness new ways of working with new technologies.

Artificial intelligence, machine learning, and advanced analytics are critical to the challenge of producing intelligence from the enormous amounts of data available to the Intelligence Community. This day-long symposium will focus on the challenge of "Big Data" and what the IC needs to do to address it. Panels will examine the IC's AIM Strategy; the importance of the Pentagon's newly created Chief Digital and AI Officer; challenges and success stories with operationalizing AI; and the capabilities needed to make it all work. Media Policy This event is open to the press. Contact [email protected] for more information.

Facial recognition in China is "absolutely correct" and "spot on", the head of the Metropolitan Police Federation has said, calling for it to be deployed in London "on a 24-hour basis". Ken Marsh, who is chairman of the Metropolitan Police staff association, said he believed the "fantastic" technology could be used to catch criminals and terrorists. Mr Marsh gave the example of the 2017 London Bridge attack, when police lost track of the terrorists in the run-up to the killings. He said: "Facial recognition, if it was pointed in certain areas in London on a 24-hour basis, could pick these individuals up… if we could have stopped that I'm all for this." The Chinese government has invested heavily in facial recognition, deploying it in the country's massive network of CCTV cameras.

VisionTrack has a clear objective to help fleets prevent incidents, reduce fraudulent claims, cut insurance premiums and, ultimately, save money. Its combined video and telematics system gives fleet operators total visibility and can be used to produce vital evidence in the wake of a collision. The company is a specialist supplier and manufacturer of vehicle CCTV technology, vehicle telematics and GPS tracking systems. Using artificial intelligence and machine learning, VisionTrack's system can provide advanced driver assistance and support driver training. It can recognise and alert the driver to potential hazards, such as an impending collision, plus identify and record dangerous driving behaviour such as tailgating and mobile phone use.

Collaboration will enable the way forward as the insurance sector adopts and deploys new technologies, according to two company CEOs who stressed partnerships Wednesday at the InsureTech Connect Conference in Las Vegas. "Regardless of the challenge, I believe there's a better way," said Tony Kuczinski, president and CEO of Munich Reinsurance America Inc. in Princeton, New Jersey. "I believe that by joining forces, we have a better chance a leveraging new ways of thinking, new technology and data, and other areas." "We have more partnerships now than at any time in our history," said Dan Glaser, president CEO of Marsh & McLennan Cos. Inc. Munich Re's own effort to accelerate the claims process in the wake of a catastrophe event involved pulling in expertise from within and outside the company, and even included a seasoned claims adjuster using his field experience to help inform an artificial intelligence system, according to Mr. Kuczinski. Mr. Glaser also said progress was a matter of priorities and focus.

Global insurance broker Marsh has appointed Andrew Hickman as global head of Data Science within its broader Digital, Data and Analytics Practice. In this newly-created role, Hickman is responsible for advancing Marsh's risk modeling and actuarial capabilities. He will build new external data and analytics partnerships in collaboration with Marsh Digital Labs to use the latest data science and machine learning techniques. Hickman brings 20 years of data science, risk modeling, and software development experience to the role. He joins Marsh from Experian DataLabs where he most recently served as vice president of Applied Research.

When University of Delaware molecular biologist Adam Marsh was studying the DNA of worms living in Antarctica's frigid seas to understand how the organisms managed to survive--and thrive--in the extremely harsh polar environment, he never imagined his work might one day have a human connection. But it turns out that the genome of these Antarctic worms is very similar to ours in terms of the number and types of genes present. And the pioneering technique Marsh developed to analyze their genetic activity is proving valuable for human health care research. Marsh and a business partner established a biotechnology company to make that technique available for such study. Specifically, Marsh's method uses next-generation genetic sequencing data to measure how cells control the way genes are turned on or off, a process known as DNA methylation.

On the face of it, Uber has had a terrible week in its legal brawl with Waymo, Google parent company Alphabet's self-driving car effort. First it suffered the public reveal of a long-awaited report that appeared to confirm Uber knew its former superstar engineer, Anthony Levandowski, took intellectual property from Google, his former employer, before it hired him. Then, over Uber's protest, the judge pushed the trial date back from this month to December, giving Waymo more time to prepare its case. To quickly sum up the case: Waymo alleges that when former star engineer Levandowski left the company in January 2016, he made off with thousands of documents containing its proprietary information, then used that intellectual property to jumpstart his own company, Otto. Uber acquired Otto for a reported $680 million in August 2016, and Waymo says Levandowski brought this stolen info with him--and that its intellectual property ended up in Uber's self-driving cars.